Skip to content
Recall Observatory FDA recall evidence

Drug product

Glimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDC 51655-120-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.

D-0552-2023

March 16, 2023

Class II

Product summary

Firm
Northwind Pharmaceuticals LLC
Event
Event 91944
Status
Ongoing
Classification
Class II
Quantity
a) 198 bottles; b) 22 bottles
Official record key
drug-enforcement:D-0552-2023

Official wording

Reason: CGMP Deviations

Code information: a) Lot #: F105692201, Exp. Date 09/30/2024; F105692203, Exp. Date 02/28/2025 b) Lot #: F105692202, Exp. Date 02/28/2025

Distribution pattern: Nationwide with the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations